Sin conexión a internet: se muestra la versión guardada de la página.

Cencora, Inc.

USUSD
← Al screener

Cencora, Inc. (LSE:0HF3) — Other Pharmaceuticals. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
cencora.com
Sector
Health Care · Other Pharmaceuticals
Sede central
Chesterbrook, United States
Consejero delegado
Steven H. Collis
Empleados
44 000
Fundada
2001
Acciones en circulación
190.83 M a 2026-07-31
Capital flotante
180.25 M
Capitalización bursátil
58.98 mil M USD
Insiders
4.3%
Inversores institucionales
99.63%
Industria (SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
ISIN
US03073E1055
LEI
AI8GXW8LG5WK7E9UD086
Ratio de reparto
17.8%
FCF
4.06 mil M USD
12%
Deuda
11.7 mil M USD
2.2 a. de FCF
Racha de dividendos
25 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksCOR principalUSD321.35 +1.29%acciones ordinarias
LSE London Stock Exchange0HF3 IOBUSD304.73 +0.00%acciones ordinarias

Precio en 3 meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Per year, US:COR: 2.4 USD (4 pagos)

Cencora, Inc. (COR) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 2.4 USD por acción (pagos: 4). Eso representa aproximadamente el 0.75% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 13.11.2026. Historial de dividendos ininterrumpido: 25 años.

Fecha exPagoImporte%TipoTicker
2026-08-142026-08-310.6000 USD0.2/0.7 %trimestralUS:COR
2026-05-152026-06-010.6000 USD0.2/0.7 %trimestralUS:COR
2026-02-132026-03-020.6000 USD0.2/0.7 %trimestralUS:COR
2025-11-142025-12-010.6000 USD0.2/0.7 %trimestralUS:COR
2025-08-152025-09-030.5500 USD0.2/0.7 %trimestralUS:COR
2025-05-162025-06-020.5500 USD0.2/0.7 %trimestralUS:COR
2025-02-142025-03-030.5500 USD0.2/≈0.7 %trimestralUS:COR
2024-11-152024-11-290.5500 USD0.2/≈0.7 %trimestralUS:COR
2024-08-092024-08-260.5100 USD0.2/≈0.6 %trimestralUS:COR
anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
BlackRock9.54%18.21 M2026-06-30
Vanguard Capital Managem…6.49%12.38 M2026-06-30
Vanguard Portfolio Manag…5.04%9.61 M2026-06-30
State Street Corporation4.86%9.27 M2026-06-30
T. Rowe Price Investment…3.88%7.41 M2026-06-30
Price (T.Rowe) Associate…3.74%7.13 M2026-06-30
JPMORGAN CHASE & CO3.11%5.94 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.07%5.87 M2026-06-30
Geode Capital Management…2.86%5.45 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.64%5.04 M2026-06-30
Boston Partners2.55%4.87 M2026-06-30
Wellington Management Gr…2.39%4.56 M2026-06-30
T. ROWE PRICE CAPITAL AP…2.33%4.44 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.1%4.01 M2026-06-30
VANGUARD SPECIALIZED FUN…1.59%3.03 M2026-07-31
iShares Trust-iShares Co…1.36%2.59 M2026-08-31
Fidelity Concord Street…1.32%2.52 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.25%2.38 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.92%1.76 M2026-06-30
-Price (T.Rowe) U.S. Val…0.85%1.62 M2026-06-30
COLLIS STEVEN HOWARD (Of…≈0.16%305 9132025-09-16
CLEARY JAMES F. JR. (Chi…≈0.08%160 3572026-03-11
MAUCH ROBERT P. (Chief E…≈0.03%65 3932026-02-20
DURCAN DERMOT MARK (Dire…≈0.02%31 7672026-06-18
BATTAGLIA SILVANA (Offic…≈0.01%23 6242026-06-30
CAMPBELL ELIZABETH S (Of…≈0.01%19 4552026-08-24
GREENBERG LON R (Directo…≈0.01%17 1282026-09-16
KRIKORIAN LAZARUS (Offic…≈0.01%16 1692026-09-01
NALLY DENNIS M (Director…≈0.01%13 1882026-07-31
The Vanguard Group———
Walgreens Boots Alliance…——2025-02-06